Journal ArticleCancer Med · December 2020
Coronavirus disease-2019 (COVID-19) has emerged as a novel infection which has spread rapidly across the globe and currently presents a grave threat to the health of vulnerable patient populations like those with malignancy, elderly, and immunocompromised. ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · December 2018
PURPOSE/OBJECTIVES: We report the outcomes of the largest cohort to date of patients receiving both bevacizumab (BEV) and fractionated stereotactic radiotherapy (FSRT) for progressive or recurrent high grade glioma (HGG). Furthermore, the sequence of these ...
Full textLink to itemCite
Journal ArticleJ Neurooncol · September 2015
The optimal treatment for patients with recurrent high grade glioma (HGG) remains controversial. Available therapies include surgery, re-irradiation, alternating electric fields or systemic therapy. Here we investigate whether re-resection will improve sur ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2015
PURPOSE: Incidental radiation dose to the heart and lung during breast radiation therapy (RT) has been associated with an increased risk of cardiopulmonary morbidity. We conducted a prospective trial to determine if RT with the Active Breathing Coordinator ...
Full textLink to itemCite
Journal ArticleRadiat Oncol · December 21, 2012
BACKGROUND: Adjuvant radiation therapy (RT) with temozolomide (TMZ) is standard of care for high grade gliomas (HGG) patients. RT is commonly started 3 to 5 weeks after surgery. The deformation of the tumor bed and brain from surgery to RT is poorly studie ...
Full textLink to itemCite
Journal ArticleNeurosurgery · August 2012
BACKGROUND: Data on radiotherapy for trigeminal schwannomas (TSs) and comparison of stereotactic radiosurgery (SRS) with fractionated stereotactic radiotherapy (FSRT) are limited. OBJECTIVE: We present a large retrospective review of our institutional expe ...
Full textLink to itemCite
Journal ArticleInt J Breast Cancer · 2012
Metabolic syndrome, which can include weight gain and central obesity, elevated serum insulin and glucose, and insulin resistance, has been strongly associated with breast cancer recurrence and worse outcomes after treatment. Epidemiologic and prospective ...
Full textLink to itemCite